TESARO, Inc.

Privately held oncology-focused biopharmaceutical company dedicated to improving the lives of cancer patients by developing and commercializing safer and more effective therapeutics

Sector: Biopharmaceuticals, Healthcare
Company Status: IPO
Investment Status: Current